These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 33173039)
21. α-Synuclein and mitochondria: partners in crime? Nakamura K Neurotherapeutics; 2013 Jul; 10(3):391-9. PubMed ID: 23512373 [TBL] [Abstract][Full Text] [Related]
22. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model. Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons. Ganjam GK; Bolte K; Matschke LA; Neitemeier S; Dolga AM; Höllerhage M; Höglinger GU; Adamczyk A; Decher N; Oertel WH; Culmsee C Cell Death Dis; 2019 Nov; 10(11):865. PubMed ID: 31727879 [TBL] [Abstract][Full Text] [Related]
24. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease. Portz P; Lee MK Cells; 2021 Apr; 10(4):. PubMed ID: 33924585 [TBL] [Abstract][Full Text] [Related]
25. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling. Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA Cells; 2020 Mar; 9(3):. PubMed ID: 32192190 [No Abstract] [Full Text] [Related]
26. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management. Phillipson OT Ageing Res Rev; 2017 Nov; 40():149-167. PubMed ID: 28986235 [TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease. Zhu XX; Zhong YZ; Ge YW; Lu KH; Lu SS Sci Rep; 2018 Aug; 8(1):12420. PubMed ID: 30127453 [TBL] [Abstract][Full Text] [Related]
33. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein. Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530 [TBL] [Abstract][Full Text] [Related]
34. α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca Paillusson S; Gomez-Suaga P; Stoica R; Little D; Gissen P; Devine MJ; Noble W; Hanger DP; Miller CCJ Acta Neuropathol; 2017 Jul; 134(1):129-149. PubMed ID: 28337542 [TBL] [Abstract][Full Text] [Related]
35. Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease. Milanese C; Cerri S; Ulusoy A; Gornati SV; Plat A; Gabriels S; Blandini F; Di Monte DA; Hoeijmakers JH; Mastroberardino PG Cell Death Dis; 2018 Jul; 9(8):818. PubMed ID: 30050065 [TBL] [Abstract][Full Text] [Related]
36. The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease. Chen Z; Rasheed M; Deng Y Brain Pathol; 2022 May; 32(3):e13012. PubMed ID: 34414627 [TBL] [Abstract][Full Text] [Related]
37. A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication. Guardia-Laguarta C; Area-Gomez E; Schon EA; Przedborski S Mov Disord; 2015 Jul; 30(8):1026-33. PubMed ID: 25952565 [TBL] [Abstract][Full Text] [Related]
38. Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Reeve AK; Ludtmann MH; Angelova PR; Simcox EM; Horrocks MH; Klenerman D; Gandhi S; Turnbull DM; Abramov AY Cell Death Dis; 2015 Jul; 6(7):e1820. PubMed ID: 26181201 [TBL] [Abstract][Full Text] [Related]
39. Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery. Picca A; Guerra F; Calvani R; Romano R; Coelho-Júnior HJ; Bucci C; Marzetti E Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680141 [TBL] [Abstract][Full Text] [Related]
40. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease. Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]